GI (Gastro-Intestinal) News is where we will put articles of interest to those with PJS. Studies, trials, and the like are generally reported in professional publications but not widely published in the major media. As articles become available, links will be given here to help keep you up to date. If you find an article you feel would be beneficial for this section, use the email link at the bottom of the page.

• Surgical & Diagnostic Procedures
• Drug Therapies & Prescription Medicines
• COX-2 Inhibitors
• Aspirin
• Colon Cancer
• Colorectal & Rectal Cancer
• Pancreatic Cancer
• General Cancer Information

Surgical & Diagnostic Procedures

• Computed tomographic virtual colonoscopy for colorectal neoplasia screening (12/5/2003)
   
• Federal funding of endoscopic research in the United States (12/5/2003)
   
• Helicobacter pylori-associated chronic gastritis and iron deficiency (11/26/2003)
   
• Operative mortality in colorectal cancer (11/25/2003)
   
• Self-reported compliance with the Universal Precautions guideline (11/21/2003)
   
• Virtual colonoscopy not yet an adequate screening tool for colorectal cancer (10/13/2003)
   
• Virtual colonoscopy still not ready for widespread use (9/5/2003)
   
• Tissue-engineered colon looks and acts like real intestine (8/4/2003)
   
• Questions raised about 5-year interval between sigmoidoscopy screening (7/1/2003)
   
• Endoscopic Imaging That's Easy to Swallow (3/2002)
   
• Given Imaging gets FDA OK for camera-in-a-pill blood indicator (3/4/2003)
   
• Colon polyp recurrence high after screening and treatment (2/24/2003)
   
• Perforation rate during colonoscopy similar to that of sigmoidoscopy (2/4/2003)
   
• Stapling method less painful than conventional hemorrhoidectomy (12/24/2002)
   

Back to Top

Drug Therapies & Prescription Medicines

• Celebrex appears to reduce drug-related small intestine lesions (10/15/2003)
   
• US FDA panel rejects Serono drug for short bowels (6/26/2003)
   
• 5-FU enhances expression of tumor antigens, perhaps cancer vaccine efficacy(5/7/2003)
   
• Down-regulation of survivin key to sulindac's anti-cancer effects (4/9/2003)
   
• Post-surgery bowel paralysis drug effective in phase III trial (4/2/2003)
   
• Synthetic vasoactive intestinal peptide analog shows promise in asthmatics (3/18/2003)
   
• Medicare head tells doctors not to prescribe Nexium (3/5/2003)
   
• Refractory inflammatory bowel disease responds to pulse cyclophosphamide (3/3/2003)
   
• Growth hormone aids parenteral nutrition in short bowel syndrome (2/18/2003)
   
• Growth factor therapy may improve epithelial function after bowel resection (1/20/2003)
   

Back to Top

• COX-2 Inhibitors
   
  • NO-releasing aspirin protects gastric mucosa when COX-2 inhibitor used (9/4/2003)
     
  • Gut safety of celecoxib demonstrated in younger patients (6/20/2003)
     
  • COX-2 inhibitor use not cost-effective in preventing colon cancer (6/6/2003)
     
  • COX-2 inhibitors not cost-effective for patients at average GI risk (5/19/2003)
     
• Aspirin
   
  • NO-releasing aspirin protects gastric mucosa when COX-2 inhibitor used (9/4/2003)
     
  • Aspirin kills H. pylori and increases its susceptibility to antibiotics (4/4/2003)
     
  • NO-donor formulation of aspirin inhibits platelets without injuring GI tract (3/18/2003)
     
  • Aspirin prevents colorectal adenomas in patients with previous neoplasia (3/5/2003)
     
  • ODC polymorphism and aspirin use tied to reduced risk of adenoma recurrence(6/16/2003)
     

Back to Top

Update: 9.Mar.'04